title: [Ductal carcinoma of the male breast].
abstract: Ductal carcinoma in the breast of a 64-year-old male is reported. Diagnosis, therapy, prognosis and follow-up are discussed. Current standard therapy is ablatio mammae, with axillary lymph node dissection. A decision in respect of chemotherapy depends on the results of staging. A follow-up control of the patients for early detection and therapy of metastasis is recommended. Our data as well as recent data from literature suggest that with respect to TNM Stages in mammary carcinoma, there is no prognostic difference between men and women.
authors.affiliation: Klinik für Gynäkologie und Geburtshilfe Stralsund.
authors.forename: M
authors.initials: M
authors.lastname: Budner
authors.forename: J
authors.initials: J
authors.lastname: Heinrich
authors.forename: F
authors.initials: F
authors.lastname: Ruhland
authors.forename: C
authors.initials: C
authors.lastname: Hielscher
mesh_terms: D018567:Breast Neoplasms, Male / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D013629:Tamoxifen